Industry
Biotechnology
Topic
Investments
People
Find news about people
Organizations
Find news about organizations
Alumni
Find news on alumni of any org
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed
Investments in Biotechnology
... Beijing-based Momenta announced this morning that it raised a $46 million Series B round ...
... In the news release, Sebacia Announces $36 Million Equity and Debt Financing to Advance Breakthrough In-Office Procedure ...
... Seattle-based Arzeda, a protein design company, has secured $12 million in Series A funding. ...
... SEATTLE, July 20, 2017 (GLOBE NEWSWIRE) -- Arzeda, The Protein Design Company, today announced that it had raised $12 million ...
... TO U.S. WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE:HEM) is pleased to announce that it ...
... biopharmaceutical companies. Dr. Stelios Papadopoulosis chairman of the board of directors of Biogen, Inc., Exelixis, Inc. and Regulus Therapeutics, Inc. He is a co-founder of ...
... Swift Biosciences, a leading provider of innovative library prep solutions for genomic sequencing, ...
... for orphan pediatric diseases, has raised $45 million in Series B funding. Arix Bioscience led the round with participation from other investors that included OrbiMed, ...
... market. SinglePoint, Inc. (OTC: SING), CV Sciences, Inc. (OTC: CVSI), GB Sciences, Inc. (OTC: GBLX), mCig, Inc. (OTC: MCIG), MassRoots Inc. (OTC: MSRT) The report ...
... Boston-based ORIG3N, a biotechnology company that is developing treatments for rare and genetically inherited ...
... Aphea.Bio, a Belgian developer of sustainable agricultural products, has raised 9 million euros ...
... PHARMACEUTICALS Syntimmune gets $50m in funding for drug development Syntimmune Inc., a four-year-old Waltham ...
... Cincinnati College of Medicine have discussed efforts to persuade the federal National Cancer Institute to bestow on its efforts the designation of "comprehensive care center." ...
... Syntimmune, Inc., a clinical-stage biotechnology company focused on FcRn biology, today announced a ...
... Checkmate Pharmaceuticals (Checkmate), a clinical-stage biopharmaceutical company focused on developing novel approaches for cancer ...
... Lattice Biologics Ltd. (TSX VENTURE: LBL) (OTCQB: LBLTF) ("Lattice Biologics" or the "Company") announced today ...
Want to see the full history of news or view news on a particular date? Upgrade to RelSci Professional now!
Start My Free Trial ➤